Back to All States

Novo Nordisk Pharmaceuticals, Inc. | Company Profile, Marketing Contacts, Media Spend, Brands




As the U.S. affiliate of Novo Nordisk A/S in Copenhagen, Denmark, Novo Nordisk Pharmaceuticals develops and manufactures biopharmaceuticals and diabetes care products. Novo Nordisk was the first company to create the insulin pen and today is a leader in human and analog insulin distribution. Novo Nordisk is also dedicated to creating pharmaceuticals for those with hemophilia and hormone deficiencies. North American headquarters are located in Princeton, NJ. ** NOTE: As a privately held subsidiary of a publicly traded parent company, annual revenue and employee count are not readily available. Therefore, the revenue and employee figures presented below are those of the parent company. **

Main Telephone
(609) 987-5800
Primary Address
800 Scudders Mill Road
Plainsboro, NJ 08536
USA

Novo Nordisk Pharmaceuticals, Inc. Contacts

Contacts (5/27)
Name Title State
Rahul G. Vice President, Clinical Development & Outcomes Research NJ
Sample of Related Brands
***********
Email: *****@*******.***
Main Phone: (609) 987-5800
Direct Phone: *** **** ***   ext: ****
Assistant Name: ** **** ***
Assistant Phone: *** **** ***
Address: 800 Scudders Mill Road

Plainsboro, NJ
08536
USA

Melissa L. Vice President, Hemophilia Marketing NJ
Bill B. Senior Director, Market Access - National Accounts NJ
Chip A. Executive Director - Insulin & Digital Health Marketing NJ
Jenn H. Director, Patient Marketing NJ

Media Spend

Media Spend Summary
Media Spend Channel

Related Brands

Brand Media Spend
Novo Nordisk Pharmaceuticals, Inc. ******
NovoLog Mix 70/30 *
NovoNorm *
InDuo *
Activella *

Agency Roster


Brand Agency Service From To
**** ******* ***************, ***. ********* ******** creative 2008 present
**** ******* ***************, ***. ********* Media Buying, Media Planning 2020 present

See Winmo sales intelligence in action

WinmoEdge

Boomer, Gen-X Women Opps: Novo Nordisk taps media AOR amid spend decreases (Score 46)


Concluding a review, Novo Nordisk (NN) assigned its $400 million US media account to Wavemaker, replacing its relationship with incumbent media AOR Publicis. NN is a healthcare organization focu...